Mode
Text Size
Log in / Sign up

Meta-analysis of ABCD Study data links genetic variants to timing of substance use initiation in adolescentsYour Teen's DNA May Shape When They First Try Drugs

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that genetic variants show suggestive associations with timing of adolescent substance use initiation in this meta-analysis.

This meta-analysis utilized longitudinal follow-up data from the Adolescent Brain Cognitive Development (ABCD) Study, which includes participants across European, African, and Hispanic ancestries. The study design treated substance use initiation timing as a time-to-event outcome, contrasting with traditional binary outcome designs often used in large-scale genetic studies. The primary outcome assessed the survival time until initiation of specific substances.

For alcohol initiation, the analysis yielded a suggestive association signal with a p-value of approximately 1 x 10^-7. Similarly, any substance use initiation showed a suggestive signal with a p-value of approximately 1 x 10^-7. Cannabis initiation also demonstrated a suggestive association signal with a p-value of approximately 5 x 10^-8. Notably, one genome-wide significant variant was identified for nicotine initiation in both fixed- and random-effects meta-analyses, with a p-value less than 5 x 10^-8.

The study did not report specific adverse events, discontinuations, or tolerability data, as these are not applicable to genetic association analyses. However, key limitations include the tendency of large-scale genetic studies to treat initiation as a binary outcome, which may underuse longitudinal timing information. Additionally, some loci exhibited cross-ancestry variation in effect estimates, and suggestive loci demonstrated limited overlap.

The practice relevance of this work demonstrates the value of incorporating developmental timing into genetic discovery. It provides a framework for integrating longitudinal risk modeling with genomic analyses, potentially refining how clinicians and researchers understand genetic contributions to substance use timing. These results highlight the need for further research to validate these associations and clarify their clinical utility.

Why timing matters so much

Substance use in teens is one of the biggest worries in public health today. About 1 in 3 high school students has tried alcohol. Nicotine vaping continues to rise. Cannabis use is climbing in many states.

The earlier a teen starts, the higher the risk of long-term problems. These include addiction, mental health struggles, and trouble in school.

But here's what's frustrating. Most prevention programs treat every teen the same. They don't know which kids are most likely to start early, and which can handle waiting.

The old way missed a key clue

Until now, most large DNA studies looked at substance use in a simple yes-or-no way. Did the teen ever try it? That's it.

But here's the twist. That approach throws away a huge piece of the puzzle.

A 14-year-old who starts drinking is very different from someone who waits until 22. Both count as "yes." But their genes, their brains, and their risks may be very different.

This new study changed the question. Instead of asking if, it asked when.

Thinking of genes like a starting gun

Imagine a race where every runner is waiting at the starting line. The gun goes off at different times for each runner based on tiny signals only they can hear.

That's how researchers now think about genes and substance use. Your DNA may act like a quiet signal that nudges some teens toward earlier experimentation, and helps others hold back longer.

The scientists used a method called a "survival GWAS." In plain English: they scanned the entire genome and looked at how long each teen went before trying a substance. This gave them a much richer view than the old yes-or-no method.

What the study looked at

The team used data from the ABCD Study. This is one of the largest long-term studies of American kids ever done. It follows thousands of children through their teen years.

They looked at four outcomes: alcohol, nicotine, cannabis, and any substance use. They also studied three ancestry groups (European, African, and Hispanic) to make sure findings worked across backgrounds.

What they found in the DNA

The researchers spotted several genetic signals linked to when teens first tried substances. For nicotine, they found one signal strong enough to meet the strictest scientific standard.

Even more interesting: some genetic signals overlapped between alcohol and general substance use. This supports an idea scientists have had for years: there's a shared "risk profile" that pushes some kids toward experimenting with many things.

But other signals were specific to just one substance. That means nicotine risk may not look the same as cannabis risk, at least in our DNA.

This doesn't mean a genetic test can predict your child's future.

This is where things get interesting

The study also showed something important about diversity. Some genetic signals acted differently in different ancestry groups. That's a reminder that research done only on European populations misses a lot.

Future studies that include everyone will be more accurate, and more fair.

How this fits the bigger picture

Experts have long known that addiction runs in families. But families share more than genes. They share stress, income, neighborhoods, and habits.

This study doesn't replace that understanding. It adds to it. Genes are one piece. Environment is another. The real power comes when scientists combine both.

Researchers hope that in the future, doctors might use a mix of DNA clues and life factors to spot teens who need extra support before they start using.

Right now, this research is still in the lab. You cannot get a DNA test that predicts when your teen might try drugs or alcohol.

What you can do is stay connected. Talk openly with your kids about substances. Pay attention to stress, friend groups, and mental health. These known risk factors still matter most.

If addiction runs in your family, tell your pediatrician. They can help with screening and prevention strategies that already work.

What the study can't tell us yet

This study is a starting point, not a finish line. The signals found were suggestive. Only one reached the strongest level of proof.

The ABCD sample, while large, is still limited. More teens from more backgrounds need to be studied. And genetics alone cannot capture the full story of why kids use substances.

Next, scientists will try to confirm these findings in larger groups. They'll also dig deeper into what these genes actually do in the brain and body.

Over time, this research could help shape smarter prevention programs. Ones that reach the right kids at the right age, long before a problem starts. That kind of tool is still years away, but studies like this one are how we get there.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundSubstance use initiation in adolescence is influenced by both genetic and environmental factors; however, large-scale genetic studies often treat initiation as a binary outcome and underuse longitudinal timing information. MethodsWe conducted time-to-event (survival) genome-wide association analyses (GWAS) of initiation for four outcomes--alcohol, nicotine, cannabis, and any substance use--using longitudinal follow-up data from the Adolescent Brain Cognitive Development (ABCD) Study. We performed ancestry-stratified GWAS within European (EUR), African (AFR), and Hispanic (HISP) groups, applying consistent quality control and covariate adjustment. Summary statistics were harmonized across ancestries and meta-analyzed using inverse-variance weighted fixed-effects and DerSimonian-Laird random-effects models. We evaluated genomic inflation and heterogeneity (Cochrans Q and I2), identified independent lead variants at genome-wide and suggestive significance thresholds, and assessed cross-trait overlap of associated loci. ResultsIn the multi-ancestry meta-analysis, we observed suggestive association signals across traits (minimum p-values: alcohol [~] 1 x 10-7, any [~] 1 x 10-7, cannabis [~] 5 x 10-8, nicotine [~] 1 x 10-8). Nicotine initiation showed one genome-wide significant variant in both fixed- and random-effects meta-analyses (p < 5 x 10-8). Across traits, suggestive loci demonstrated limited overlap, with the strongest concordance between alcohol and any substance use, consistent with shared liability. Heterogeneity statistics indicated that some loci exhibited cross-ancestry variation in effect estimates. ConclusionsSurvival GWAS leveraging initiation timing can identify genetic signals that may be missed by binary designs and enables principled multi-ancestry synthesis. Our results highlight both shared and trait-specific genetic contributions to early substance initiation and provide a foundation for downstream functional annotation and integrative modeling with environmental risk factors. These findings demonstrate the value of incorporating developmental timing into genetic discovery and provide a framework for integrating longitudinal risk modeling with genomic analyses.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.